참고문헌
- An YL, Nie F, Wang ZY, Zhang DS. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells. International Journal of Nanomedicine. 2011 ; 6 : 3187-94.
- Westphal M, Lamszus K. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci. 2011 ; 12(9) : 495-508. https://doi.org/10.1038/nrn3060
- Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007 ; 21(21) : 2683-710. https://doi.org/10.1101/gad.1596707
- Guo G, Yao W, Zhang Q, Bo Y. Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating mapk/erk signaling pathway. PLoS ONE. 2013 ; 8(8) : e72079. https://doi.org/10.1371/journal.pone.0072079
- Auffinger B, Thaci B, Ahmed A, Ulasov I, Lesniak MS. MicroRNA targeting as a therapeutic strategy against glioma. Curr Mol Med. 2013 ; 13(4) : 535-42. https://doi.org/10.2174/1566524011313040006
- Ciechomska IA, Gabrusiewicz K, Szczepankiewicz AA, Kaminska B. Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine a-induced cell death. Oncogene. 2013 ; 32(12) : 1518-29. https://doi.org/10.1038/onc.2012.174
- Lowe DB, Storkus WJ. Chronic inflammation and immunologic- based constraints in malignant disease. Immunotherapy. 2011 ; 3(10) : 1265-74. https://doi.org/10.2217/imt.11.113
- Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010 ; 31(1) : 37-49. https://doi.org/10.1093/carcin/bgp272
- Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radical Biology & Medicine. 2012 ; 52(9) : 2013-37. https://doi.org/10.1016/j.freeradbiomed.2012.02.035
- Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell. 2010 ; 140(6) : 883-99. https://doi.org/10.1016/j.cell.2010.01.025
- Hur J. Dong-eui-bo-gam. Seoul : Bupin Publishing Co., Ltd. 2007 : 1980.
- Ahn DK. Illustrated Book of Korean Medicinal Herbs. 331. Seoul : Kyo-Hak Publishing Co., Ltd. 2006 : 518.
- Lee JJ, Moon JY. Antioxidant property of Aqua-Acupuncture solution from Circium japonicum. Korean Journal of Acupuncture. 2005 ; 22(4) : 57-65.
- Lee JJ, Kim H, Yi HS, Park WH, Moon JY. Suppression of Lipid Peroxidation and CYP Isozymes activities by Circium japonicum Herbal-acupuncture solution; Basic study for screening of medicinal herb on reactive oxygen radical and CYP-mediated atherosclerosis. Korean Journal of Acupuncture. 2006 ; 23(4) : 177-86.
- Dela Peña IJ, Lee HL, Yoon SY, Dela Peña JB, Kim HK, Hong EY, et al. The ethanol extract of Cirsium japonicum increased chloride ion influx through stimulating GABA(A) receptor in human neuroblastoma cells and exhibited anxiolytic-like effects in mice. Drug Discoveries & Therapeutics. 2013 ; 7(1) : 18-23.
- Jung HA, Jin SE, Min BS, Kim BW, Choi JS. Anti-inflammatoryactivity of Korean thistle Cirsium maackii and its major flavonoid, luteolin 5-O-glucoside. Food Chem Toxicol. 2012 ; 50(6) : 2171-9. https://doi.org/10.1016/j.fct.2012.04.011
- Liu S, Luo X, Li D, Zhang J, Qiu D, Liu W, et al. Tumor inhibition and improved immunity in mice treated with flavone from Cirsium japonicum DC. International Immunopharmacology. 2006 ; 6(9) : 1387-93. https://doi.org/10.1016/j.intimp.2006.02.002
- Liu S, Zhang J, Li D, Liu W, Luo X, Zhang R, et al. Anticancer activity and quantitative analysis of flavone of Cirsium japonicum DC. Nat Prod Res. 2007 ; 21(10) : 915-22. https://doi.org/10.1080/14786410701494686
- Kim DY, Kang SH, Ghil SH. Cirsium japonicum extract induces apoptosis and anti-proliferation in the human breast cancer cell line MCF-7. Mol Med Rep. 2010 ; 3(3) : 427-32.
- Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007 ; 10(11) : 1387-94. https://doi.org/10.1038/nn1997
- Zong H, Verhaak RG, Canoll P. The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn. 2012 ; 12(4) : 383-94. https://doi.org/10.1586/erm.12.30
- Kim Y. Regulation of cell proliferation and migration in glioblastoma: new therapeutic approach. Front Oncol. 2013 ; 3 : 53.
- Gao Z, Cheng P, Xue Y, Liu Y. Vascular endothelial growth factor participates in modulating the C6 glioma-induced migration of rat bone marrow-derived mesenchymal stem cells and upregulates their vascular cell adhesion molecule-1 expression. Experimental and Therapeutic Medicine. 2012 ; 4(6) : 993-8.
- Muntane J, la Mata MD. Nitric oxide and cancer. World J Hepatol. 2010 ; 2(9) : 337-44. https://doi.org/10.4254/wjh.v2.i9.337
- Rakoff-Nahoum S. Why Cancer and Inflammation. Yale J Biol Med. 2006 ; 79(3-4) : 123-30.
- Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, et al. Cancer and Inflammation: Promise for Biological Therapy. J Immunother. 2010 ; 33(4) : 335-51. https://doi.org/10.1097/CJI.0b013e3181d32e74
- Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer. 2007 ; 121 : 2373-80. https://doi.org/10.1002/ijc.23173
- Wu Y, Antony S, Meitzler JL, Doroshow JH. Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Letters. 2013.
- Jiang Q, Zhou Z, Wang L, Wang L, Yue F, Wang J, et al. A Scallop Nitric Oxide Synthase (NOS) with Structure Similar to Neuronal NOS and Its Involvement in the Immune Defense. PLoS One. 2013 ; 8(7) : e69158. https://doi.org/10.1371/journal.pone.0069158
- Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010 ; 23(2) : 75-93. https://doi.org/10.1016/j.niox.2010.04.007
- Lieb K, Engels S, Fiebich BL. Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochemistry International. 2003 ; 42(2) : 131-7. https://doi.org/10.1016/S0197-0186(02)00076-1
- Xu X, Malave A. P38 MAPK, but not p42/p44 MAPK mediated inducible nitric oxide synthase expression in C6 glioma cells. Life Sci. 2000 ; 67(26) : 3221-30. https://doi.org/10.1016/S0024-3205(00)00902-4
- Ganster RW, Taylor BS, Shao L, Geller DA. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc Natl Acad Sci USA. 2001 ; 98(15) : 8638-43. https://doi.org/10.1073/pnas.151239498
- Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007 ; 8(1) : 57-69. https://doi.org/10.1038/nrn2038
- Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol. 2003 ; 27(3) : 325-55. https://doi.org/10.1385/MN:27:3:325
- Clerk A, Sugden PH. Untangling the Web: specific signaling from PKC isoforms to MAPK cascades. Circ Res. 2001 ; 89(10) : 847-9.
- Lee SJ, Lim KT. Inhibitory effect of 30-kDa phytoglycoprotein on expression of TNF-alpha and COX-2 via activation of PKC-alpha and ERK 1/2 in LPS-stimulated RAW 264.7 cells. Mol Cell Biochem. 2008 ; 317(1-2) : 151-9. https://doi.org/10.1007/s11010-008-9843-0
-
Chen CC, Wang JK, Lin SB. Antisense Oligonucleotides Targeting Protein Kinase C-
$\alpha$ , -$\beta$ I, or -$\delta$ But Not -$\eta$ Inhibit Lipopolysaccharide-Induced Nitric Oxide Synthase Expression in RAW 264.7 Macrophages: Involvement of a Nuclear Factor kB-Dependent Mechanism. The Journal of Immunology. 1998 ; 161 : 6206-14. - Lin TH, Kuo HC, Chou FP, Lu FJ. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer. 2008 ; 8 : 58. https://doi.org/10.1186/1471-2407-8-58
- Hu JG, Wang XF, Zhou JS, Wang FC, Li XW, Lu HZ. Activation of PKC-alpha is required for migration of C6 glioma cells. Acta Neurobiol Exp (Wars). 2010 ; 70 : 239-45.
- Lee KG, Cho HJ, Bae YS, Park KK, Choe JY, Chung IK, et al. Bee venom suppresses LPS-mediated NO/iNOS induction through inhibition of PKC-alpha expression. J Ethnopharmacol. 2009 ; 123(1) : 15-21. https://doi.org/10.1016/j.jep.2009.02.044